Assessment of Pain in People With Thalassemia (Pain)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00872339 |
Recruitment Status :
Completed
First Posted : March 31, 2009
Results First Posted : June 5, 2014
Last Update Posted : June 5, 2014
|
Sponsor:
HealthCore-NERI
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
HealthCore-NERI
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Observational |
---|---|
Study Design | Observational Model: Cohort; Time Perspective: Prospective |
Condition |
Thalassemia |
Enrollment | 252 |
Participant Flow
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | Transfusion-dependant | Intermittently Transfused | Non-transfusion-dependant |
---|---|---|---|
![]() |
People with transfusion-dependant thalassemia. | Intermittently transfused patients- individuals who received fewer than eight transfusions in the last year | People with non-transfusion-dependant thalassemia. |
Period Title: Overall Study | |||
Started | 201 | 14 | 37 |
Completed | 201 | 14 | 37 |
Not Completed | 0 | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Transfusion-dependant | Intermittently Transfused | Non-transfusion-dependant | Total | |
---|---|---|---|---|---|
![]() |
People with transfusion-dependant thalassemia. | Intermittently transfused patients- individuals who received fewer than eight transfusions in the last year | People with non-transfusion-dependant thalassemia. | Total of all reporting groups | |
Overall Number of Baseline Participants | 201 | 14 | 37 | 252 | |
![]() |
[Not Specified]
|
||||
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
|||||
Number Analyzed | 201 participants | 14 participants | 37 participants | 252 participants | |
28.2 (10.4) | 35.8 (14.4) | 29.5 (16.2) | 28.8 (11.8) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
|||||
Number Analyzed | 201 participants | 14 participants | 37 participants | 252 participants | |
Female |
117 58.2%
|
6 42.9%
|
14 37.8%
|
137 54.4%
|
|
Male |
84 41.8%
|
8 57.1%
|
23 62.2%
|
115 45.6%
|
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Felicia Trachtenberg |
Organization: | New England Research Institutes |
Phone: | 6179723120 |
EMail: | ftrachtenberg@neriscience.com |
Responsible Party: | HealthCore-NERI |
ClinicalTrials.gov Identifier: | NCT00872339 |
Other Study ID Numbers: |
639 U01HL065238 ( U.S. NIH Grant/Contract ) |
First Submitted: | March 30, 2009 |
First Posted: | March 31, 2009 |
Results First Submitted: | January 2, 2014 |
Results First Posted: | June 5, 2014 |
Last Update Posted: | June 5, 2014 |